Brief: Aprea Therapeutics Says Entered Into An At Market Offering Agreement With HC Wainwright & Co
Jan 26 (Reuters) - Aprea Therapeutics Inc APRE.O :
* APREA THERAPEUTICS INC - ENTERED INTO AN AT MARKET
OFFERING
AGREEMENT WITH H.C. WAINWRIGHT & CO., LLC
* APREA THERAPEUTICS INC - MAY OFFER AND SELL COMMON STOCK
FROM
TIME TO TIME OF UP TO $1.0 MILLION DURING TERM OF SALES
AGREEMENT
Further company coverage: APRE.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Aprea Therapeutics
See all newsAprea Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Aprea Therapeutics Q2 net loss widens on higher R&D costs
Aprea Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Aprea Therapeutics Provides Acesot-1051 Program Update For Wee1 Inhibitor Apr-1051 Accelerating And Expanding Enrollment. Clinical Data Presentation Planned For Q4 2026
Brief: Aprea Therapeutics - Files For Resale Of Up To 5.5 Million Shares By Selling Stockholders - SEC Filing